DCIS to Stage III Lobular Breast Cancer After 12 Years ...

I'm not just the President of My Girls Skin Care, I'm also part of the My Girls Community having undergone treatment for Ductal Carcinoma In Situ or DCIS, in my left breast 12 years ago and now again this year; Lobular Cancer in my right breast. While my DCIS was non-invasive breast cancer, meaning the cancer was contained to the milk duct and considered non-life threatening, the pathology indicated an increased risk of developing Lobular Cancer In Situ or LCIS in the left breast. Briefly, Lobular carcinoma in situ is an area (or areas) of abnormal cell growth that increases a person’s risk of developing invasive breast cancer later on and occurs in the milk-producing glands at the end of breast ducts.

I worried about this diagnosis and the serious tone in which the MGH Fellow took while reviewing it with me. When I dragged my feet after radiation therapy treatments wrapped up, the smart, young fellow hounded me with phone calls urging me to start my 5 year course of Tamoxifen, an estrogen blocker used since 1998 to treat millions of women and men diagnosed with hormone-receptor-positive breast cancer. I was only 41 and Stage 0, yet the threat of LCIS and the aggressive nature of the tumor was cause for concern he said. He was right. 12 years later in May of 2019, I found a lump which was biopsied to reveal Stage III Lobular Cancer, undetected in annual mammograms and MRIs which I had diligently continued from 2008 through 2015; 6 years following my initial diagnosis.

I am in treatment once again and coming to terms with it having finished up a partial mastectomy at Massachusetts General Hospital in early June and now moving on to Chemotherapy and Radiation at Oregon Health and Sciences University after a move the Pacific Northwest a few months before my diagnosis.

I am so grateful to my original team at Mass General, they moved swiftly and removed the tumor which had grown to more than 5 cm calling me often at 5 a.m. PST as they sought to fit me into an already crowded schedule. I felt as if I was being cared for by a small community hospital in the careful and personal attention they gave to my case. I am also grateful to my team at OHSU as their expertise and concern for my well-being is so comforting as well as their recently completed state-of-the-art OHSU Knight Cancer Institute. They have made me feel at home in a new and unfamiliar setting as I go through treatments without family or close friends nearby.

As we need to support each other during difficult times, I invite you to Like My Girls Skin Care by clicking on the link here @ My Girls Community and share with others like yourself to help others through a difficult time. Caretakers, family and friends are also welcome!  In return, we post news of treatment centers providing free patient samples for friends and family in need, news of advancements in quality of care plus product discounts; for example a 25% discount on our Gifts of Comfort for people undergoing cancer treatments that dry and overly compromise the skin.

Since I founded My Girls, my goal has been to provide a better standard of comfort during radiation therapy for breast cancer. Today, My Girls is recommended in over 1,000 U.S. hospitals for breast, head and neck, lung and other cancers that compromise the skin and for help with diminishing and healing surgical wounds. This gives me great joy and strength as I move on to the next chapter and I hope that you will join me in expanding ways in which we may offer comfort to others undergoing cancer treatments.

Thank you for your support over the years!

Be well,
Theresa Keresztes
Founder & President